MedTrace Logo

Biomarker Changes in Samples From Young Patients With Acute Myeloid Leukemia

NCT01139931 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2016-05-18

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood or tumor tissue from patients with cancer in the laboratory may help doctors learn about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is studying biomarker changes in samples from young patients with acute myeloid leukemia.

Conditions

Interventions

GENETIC

DNA methylation analysis

GENETIC

gene expression analysis

GENETIC

microarray analysis

GENETIC

polymorphism analysis

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Soheil Meshinchi, MD · Fred Hutchinson Cancer Center

Eligibility

Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2016-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01139931 on ClinicalTrials.gov